Absea-Absea Biotechnology Ltd.

Your privacy is very important to us.When you visit our website,please agree to the use of all cookies.For more information about personal data processing,please go to Privacy.

  • a1banpc.jpg a1banph.jpg
    EMPOWERING
    PROTEIN SCIENCE
    Absea develops, engineers and characterizes protein and antibody reagents at unprecedented throughput and quality.
  • a1banpc21.jpg a1banph2.jpg
    EMPOWERING
    PROTEIN SCIENCE
    We strive to provide products, services and tools to break new ground in protein research and industry.

RECOMMENDED PRODUCTS

  • a1icon01.svg a1icon011-850.svg

    Cytokine
    antibodies

  • a1icon02.svg a1icon021.svg

    Ig-targeting
    antibodies

  • a1icon03.svg a1icon031.svg

    IHC
    antibodies

  • a1icon04.svg a1icon041.svg

    Neuroprotein
    antibodies

  • a1icon05.svg a1icon051.svg

    Recombinant
    proteins

  • a1img011.jpg
    Cytokine
    antibodies

    Cytokines are a diverse group of small proteins secreted by the cells of innate and adaptive immunity in response to microbes and other antigens. Absea offers mAbs against a wide range of cytokines including interleukins, interferons, chemokines and others.

  • a1img021.jpg
    Ig-targeting
    antibodies

    Antibodies, also known as immunoglobulins, are Y-shaped glycoproteins that bind to specific antigens as part of the antimicrobial immune response. Absea provides mAbs targeting various immunoglobulin subtypes and fragments.

  • a1img031.jpg
    IHC
    antibodies

    Immunohistochemistry is one of the most widely used methods to detect protein markers in tissue. Absea's immunohistochemical (IHC) mAbs cover many research fields including angiogenesis, tumor marker profiling, cell signaling and others.

  • a1img04.jpg
    Neuroprotein
    antibodies

    Neuroproteins are important regulators of brain function. Their correct expression and folding is crucial for our health. Absea's mAbs for neurobiology cover a wide range of targets such as proteins involved neurodegeneration and neurotransmission.

  • a1img05.jpg
    Recombinant
    proteins

    Recombinant proteins are essential for in vitro biochemistry and structural biology. Absea has a large portfolio of soluble, recombinant proteins for numerous applications, ranging from generating analytical standards to studying structure-function relationships.

INTRODUCING ABSEA

Absea, located in the vibrant Life Science Park of Beijing, is committed to cutting-edge protein research. Absea has established outstanding protein R&D and technology platforms. Today, Absea has built the world's largest high-throughput protein expression platform and soluble human protein repository, and develops monoclonal antibodies to target the entire proteome. As a driver of innovation, Absea is augmenting its expertise in protein biotechnology with the power of state-of-the-art AI and bioinformatics tools. With this unique skill set, Absea is emerging as a rising star in proteome science and actively expanding its services into in vitro diagnostics, life science research and biopharmaceuticals.


Learn More →


  • a1icon07.svg

    10000+

    Human proteins produced

  • a1icon08.svg

    2000+

    Custom mAb projects

  • a1icon06.svg

    600+

    New proteins per month

  • a1icon07-42.svg

    200+

    New antibodies per month

a1img061.jpg